
Up to 80% of patients with hepatocellular carcinoma will experience disease recurrence.

Up to 80% of patients with hepatocellular carcinoma will experience disease recurrence.

Tzield does not have any known contraindications.

The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.

Products include deodorant and pain medication that uses a plant-based formula.

Both barriers and facilitating factors, as well as a history of STIs, are associated with recent PrEP use among urban transgender women.

A higher carbohydrate diet was linked to earlier sleep and wake times, despite low carbohydrate consumption among study participants.

Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.

Cate Lockhart, PharmD, PhD, executive director of the Biologics and Biosimilars Collective Intelligence Consortium, discussed the growing biosimilars landscape .

Infants diagnosed with invasive Group B Streptococcus meningitis had an increased risk of developing epilepsy if the mother was of lower income.

Prediagnostic weight loss could be an important marker for colorectal cancer diagnosis.

The SUNRISE-3 trial is investigating its use in high-risk patients regardless of COVID-19 vaccination status.

While the demand for professionals adept in the ability to work with big data is at an all-time high, there remains a significant lack of skilled talent.

Study results indicate a decrease in the exclusion of older adults but no significant change for individuals who are immunocompromised.

Even before the Dobbs ruling overturned country-wide reproductive rights, the oncology field was already facing a dearth of maternal care access challenges.

Six weeks after infusion of GD2-CART01, 9 of 27 patients (33%) with relapsed or refractory high-risk neuroblastoma had a complete response or maintained a complete response.

Limitations on a woman’s options when pregnant and diagnosed with cancer can directly impact her ability to save her own life and preserve her fertility for future pregnancies.

Products include treatment for major depressive disorder and severe asthma.

The FDA considers alcohol hangover as a disease, requiring treatments to be registered as drugs.

The remaining requirements of the law will go into affect on November 27, 2023.

The data were published during Black Maternal Health Week.

Individual alleges that an equivalent product from another manufacturer precipitated series of seizures.

The crucial role of self-care pharmacy practice requires that pharmacists develop a robust understanding of the implications of the current and proposed regulatory changes for nonprescription drugs.

Choosing the best biosimilar based on reimbursement can be challenging.

Lowering blood pressure could be dangerous for people with normal blood pressure.

A 10% increase in the proportion of adults aged 50 years or older was associated with a 1.2% increase in pneumococcal vaccination coverage.

Infusion reactions in the switching group did not occur with switching, but rather only with reference trastuzumab administration.

Annual Asembia summit features insights from key opinion leaders, networking events, and continuing education sessions for pharmacists, pharmacy staff and stakeholders.

The results of a review, published in Cureus, show that the medications reduced the risk of HF.

Efficacy and safety data for BeiGene’s therapy shows positive results for individuals with advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

The gene-editing technology has been used successfully in a pediatric patient with T-cell ALL.